Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiyuan Li

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Frontiers in Genetics|August 25, 2025
From ownership to custodianship: rethinking human biospecimens data governance in the Chinese contextYifan Peng, Jiyuan Li, Ruipeng Lei
Expert Opinion on Drug Safety|January 9, 2020
The adverse-effect profile of lacosamideJiyuan Li, Meizhen Sun, Xuefeng Wang
Cells|June 11, 2025
FGF-Mediated Axon Guidance: Role of Downstream Signaling Pathways in Cytoskeletal ControlJiyuan Li, Hanqi Gao, Fang Liu
Theranostics|January 12, 2023
Radiopharmaceuticals heat anti-tumor immunityQi Sun, Jiyuan Li, Zexuan Ding, et al.
Journal of the American Nutrition Association|May 28, 2025
Exploring the Epidemiology and Molecular Mechanisms of Riboflavin Against Chronic Kidney Disease Based on Data Mining, Single-Cell RNA Sequencing and Molecular DockingZiyi Liu, Jiyuan Li, Fenghua Peng, et al.
Proteome Science|March 27, 2012
Proteomic analysis of effluents from perfused human heart for transplantation: identification of potential biomarkers for ischemic heart damageHong Li, Jiyuan Li, Ying Wang, et al.
Cancer Biomarkers : Section a of Disease Markers|August 2, 2017
Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinomaShuaiyu Zheng, Xiaojin Zhang, Xian Wang, et al.
The Analyst|March 16, 2021
PD-L1 aptamer isolation via Modular-SELEX and its applications in cancer cell detection and tumor tissue section imagingJiyuan Li, Xijiao Ren, Jiaxing Zhao, et al.
Oncology Letters|January 19, 2019
MIR31HG promotes cell proliferation and invasion by activating the Wnt/β-catenin signaling pathway in non-small cell lung cancerShuaiyu Zheng, Xiaojin Zhang, Xian Wang, et al.
Expert Opinion on Drug Safety|April 19, 2021
Malignant syndromes: current advancesMinghua Tao, Jiyuan Li, Xuefeng Wang, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Frontiers in Genetics|August 25, 2025
From ownership to custodianship: rethinking human biospecimens data governance in the Chinese contextYifan Peng, Jiyuan Li, Ruipeng Lei
Expert Opinion on Drug Safety|January 9, 2020
The adverse-effect profile of lacosamideJiyuan Li, Meizhen Sun, Xuefeng Wang
Cells|June 11, 2025
FGF-Mediated Axon Guidance: Role of Downstream Signaling Pathways in Cytoskeletal ControlJiyuan Li, Hanqi Gao, Fang Liu
Theranostics|January 12, 2023
Radiopharmaceuticals heat anti-tumor immunityQi Sun, Jiyuan Li, Zexuan Ding, et al.
Journal of the American Nutrition Association|May 28, 2025
Exploring the Epidemiology and Molecular Mechanisms of Riboflavin Against Chronic Kidney Disease Based on Data Mining, Single-Cell RNA Sequencing and Molecular DockingZiyi Liu, Jiyuan Li, Fenghua Peng, et al.
Proteome Science|March 27, 2012
Proteomic analysis of effluents from perfused human heart for transplantation: identification of potential biomarkers for ischemic heart damageHong Li, Jiyuan Li, Ying Wang, et al.
Cancer Biomarkers : Section a of Disease Markers|August 2, 2017
Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinomaShuaiyu Zheng, Xiaojin Zhang, Xian Wang, et al.
The Analyst|March 16, 2021
PD-L1 aptamer isolation via Modular-SELEX and its applications in cancer cell detection and tumor tissue section imagingJiyuan Li, Xijiao Ren, Jiaxing Zhao, et al.
Oncology Letters|January 19, 2019
MIR31HG promotes cell proliferation and invasion by activating the Wnt/β-catenin signaling pathway in non-small cell lung cancerShuaiyu Zheng, Xiaojin Zhang, Xian Wang, et al.
Expert Opinion on Drug Safety|April 19, 2021
Malignant syndromes: current advancesMinghua Tao, Jiyuan Li, Xuefeng Wang, et al.
Pageof 15